Larissa A Meyer MD MPH (She/Her)
Gynecologic Oncology
Associate Professor, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston
Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6810
Dr. Meyer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Gynecologic Oncology, 2007 - 2011
New York Presbyterian Hospital (Cornell Campus)Residency, Obstetrics and Gynecology, 2002 - 2006
Harvard Medical SchoolClass of 2002
Certifications & Licensure
FL State Medical License 2021 - Present
TX State Medical License 2008 - 2026
WA State Medical License 2023 - 2026
AL State Medical License 2023 - 2025
AZ State Medical License 2023 - 2025
GA State Medical License 2023 - 2025
LA State Medical License 2023 - 2025
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
- Join now to see all
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2012 Jun 18
- Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamous Cell Cancer of the Vulva Start of enrollment: 2012 Jul 02
- Self-Hypnosis for the Enhanced Recovery After Surgery in Patients with Gynecologic Cancer Start of enrollment: 2018 Sep 11
Publications & Presentations
PubMed
- Neuroendocrine cervical carcinomas: genomic insights, controversies in treatment strategies, and future directions: a NeCTuR study.Gloria Salvo, Larissa A Meyer, Naomi R Gonzales, Michael Frumovitz, R Tyler Hillman
International Journal of Gynecological Cancer. 2025-03-01 - Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update.Stéphanie Gaillard, Christina Lacchetti, Deborah K Armstrong, William A Cliby, Mitchell I Edelson
Journal of Clinical Oncology. 2025-03-01 - Use Patterns of Levonorgestrel-Releasing Intrauterine System among American Women.Paul G Yeh, Allen Haas, Charlotte C Sun, Karen H Lu, Larissa A Meyer
Cancer Prevention Research. 2025-02-11
Journal Articles
- A Prospective Randomized Trial Comparing Liposomal Bupivacaine vs. Standard Bupivacaine Wound Infiltration in Open Gynecologic Surgery on an Enhanced Recovery PathwayLarissa A Meyer, Javier Lasala, Gabriel Mena, American Journal of Obstetrics and Gynecology
Authored Content
- A Prospective Randomized Trial Comparing Liposomal Bupivacaine vs. Standard Bupivacaine Wound Infiltration in Open Gynecologic Surgery on an Enhanced Recovery PathwayJuly 2020
- A Prospective Randomized Trial Comparing Liposomal Bupivacaine vs. Standard Bupivacaine Wound Infiltration in Open Gynecologic Surgery on an Enhanced Recovery PathwayJuly 2020
Press Mentions
MD Anderson Secures Nearly $23 Million in CPRIT Grants for Cancer Research and Faculty RecruitmentFebruary 19th, 2025- "Author Reply to "Commentary on A Specific Bacterial DNA Signature in the Vagina of Australian Women in Midpregnancy Predicts High Risk of Spontaneous Preterm Birth (The Predict1000 Study)""February 6th, 2021
- Patient Cost-Sharing During Poly(ADP-Ribose) Polymerase Inhibitor Treatment in Ovarian CancerFebruary 4th, 2021
- Join now to see all
Professional Memberships
- Fellow
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
